HC
The startup develops a genomics platform that enhances genetic testing accuracy by analyzing the functional significance of genetic variations and mutations in the human genome. This technology enables improved interpretation of genetic tests for rare diseases and cancer, facilitating the conversion of generic drugs into targeted precision medicines.
Updated 3 months ago
Funding
$6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a genomics platform that enhances genetic testing accuracy by analyzing the functional significance of genetic variations and mutations in the human genome. This technology enables improved interpretation of genetic tests for rare diseases and cancer, facilitating the conversion of generic drugs into targeted precision medicines.